Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Semifluorinated Alkane Eye Drops for Treatment of Dry Eye Disease Due to Meibomian Gland Disease.
Steven P, Augustin AJ, Geerling G, Kaercher T, Kretz F, Kunert K, Menzel-Severing J, Schrage N, Schrems W, Krösser S, Beckert M, Messmer EM. Steven P, et al. Among authors: beckert m. J Ocul Pharmacol Ther. 2017 Nov;33(9):678-685. doi: 10.1089/jop.2017.0042. Epub 2017 Sep 18. J Ocul Pharmacol Ther. 2017. PMID: 28922088 Free PMC article. Clinical Trial.
A Clinical Phase II Study to Assess Efficacy, Safety, and Tolerability of Waterfree Cyclosporine Formulation for Treatment of Dry Eye Disease.
Wirta DL, Torkildsen GL, Moreira HR, Lonsdale JD, Ciolino JB, Jentsch G, Beckert M, Ousler GW, Steven P, Krösser S. Wirta DL, et al. Among authors: beckert m. Ophthalmology. 2019 Jun;126(6):792-800. doi: 10.1016/j.ophtha.2019.01.024. Epub 2019 Jan 28. Ophthalmology. 2019. PMID: 30703441 Free PMC article. Clinical Trial.
Efficacy and tolerability of atorvastatin/fenofibrate fixed-dose combination tablet compared with atorvastatin and fenofibrate monotherapies in patients with dyslipidemia: a 12-week, multicenter, double-blind, randomized, parallel-group study.
Davidson MH, Rooney MW, Drucker J, Eugene Griffin H, Oosman S, Beckert M; LCP-AtorFen Investigators. Davidson MH, et al. Among authors: beckert m. Clin Ther. 2009 Dec;31(12):2824-38. doi: 10.1016/j.clinthera.2009.12.007. Clin Ther. 2009. PMID: 20110022 Clinical Trial.
A first-in-man phase 1 trial for long-acting TransCon Growth Hormone.
Gilfoyle D, Mortensen E, Christoffersen ED, Leff JA, Beckert M. Gilfoyle D, et al. Among authors: beckert m. Growth Horm IGF Res. 2018 Apr;39:34-39. doi: 10.1016/j.ghir.2017.12.002. Epub 2017 Dec 5. Growth Horm IGF Res. 2018. PMID: 29273485 Clinical Trial.
Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial.
Thornton PS, Maniatis AK, Aghajanova E, Chertok E, Vlachopapadopoulou E, Lin Z, Song W, Christoffersen ED, Breinholt VM, Kovalenko T, Giorgadze E, Korpal-Szczyrska M, Hofman PL, Karpf DB, Shu AD, Beckert M. Thornton PS, et al. Among authors: beckert m. J Clin Endocrinol Metab. 2021 Oct 21;106(11):3184-3195. doi: 10.1210/clinem/dgab529. J Clin Endocrinol Metab. 2021. PMID: 34272849 Free PMC article. Clinical Trial.
The effect of anti-L-selectin (aselizumab) in multiple traumatized patients--results of a phase II clinical trial.
Seekamp A, van Griensven M, Dhondt E, Diefenbeck M, Demeyer I, Vundelinckx G, Haas N, Schaechinger U, Wolowicka L, Rammelt S, Stroobants J, Marzi I, Brambrink AM, Dziurdzik P, Gasiorowski J, Redl H, Beckert M, Khan-Boluki J. Seekamp A, et al. Among authors: beckert m. Crit Care Med. 2004 Oct;32(10):2021-8. doi: 10.1097/01.ccm.0000142396.59236.f3. Crit Care Med. 2004. PMID: 15483410 Clinical Trial.
A Randomized Phase 2 Study of Long-Acting TransCon GH vs Daily GH in Childhood GH Deficiency.
Chatelain P, Malievskiy O, Radziuk K, Senatorova G, Abdou MO, Vlachopapadopoulou E, Skorodok Y, Peterkova V, Leff JA, Beckert M; TransCon GH Working Group. Chatelain P, et al. Among authors: beckert m. J Clin Endocrinol Metab. 2017 May 1;102(5):1673-1682. doi: 10.1210/jc.2016-3776. J Clin Endocrinol Metab. 2017. PMID: 28201598 Clinical Trial.
Response to Letter to the Editor From L. Sävendahl et al: "Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial".
Thornton PS, Maniatis AK, Aghajanova E, Chertok E, Vlachopapadopoulou E, Lin Z, Song W, Christoffersen ED, Breinholt VM, Kovalenko T, Giorgadze E, Korpal-Szczyrska M, Hofman PL, Karpf DB, Shu AD, Beckert M. Thornton PS, et al. Among authors: beckert m. J Clin Endocrinol Metab. 2022 Feb 17;107(3):e1333-e1334. doi: 10.1210/clinem/dgab738. J Clin Endocrinol Metab. 2022. PMID: 34626470 Free PMC article. No abstract available.
Response to Letter to the Editor From Malozowski: "Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial".
Thornton PS, Maniatis AK, Aghajanova E, Chertok E, Lin Z, Song W, Christoffersen ED, Breinholt VM, Giorgadze E, Korpal-Szczyrska M, Hofman PL, Karpf DB, Shu AD, Beckert M. Thornton PS, et al. Among authors: beckert m. J Clin Endocrinol Metab. 2022 Apr 19;107(5):e2215-e2216. doi: 10.1210/clinem/dgab879. J Clin Endocrinol Metab. 2022. PMID: 34915563 Free PMC article. No abstract available.
67 results